InMed Pharmaceuticals, Inc. (INM)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 25, 15:03
InMed Pharmaceuticals Total Liabilities (Quarterly) : 2.242M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.242M |
| December 31, 2025 | 1.604M |
| September 30, 2025 | 1.770M |
| June 30, 2025 | 2.146M |
| March 31, 2025 | 2.258M |
| December 31, 2024 | 2.320M |
| September 30, 2024 | 2.070M |
| June 30, 2024 | 2.617M |
| March 31, 2024 | 2.254M |
| December 31, 2023 | 2.483M |
| September 30, 2023 | 1.339M |
| June 30, 2023 | 2.017M |
| March 31, 2023 | 2.342M |
| December 31, 2022 | 2.585M |
| September 30, 2022 | 3.576M |
| June 30, 2022 | 3.709M |
| March 31, 2022 | 4.599M |
| December 31, 2021 | 5.216M |
| September 30, 2021 | 2.106M |
| June 30, 2021 | 2.405M |
| March 31, 2021 | 1.930M |
| December 31, 2020 | 3.263M |
| September 30, 2020 | 2.107M |
| June 30, 2020 | 1.924M |
| March 31, 2020 | 1.627M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.576M |
| September 30, 2019 | 1.414M |
| June 30, 2019 | 1.196M |
| March 31, 2019 | 0.4999M |
| December 31, 2018 | 0.4028M |
| September 30, 2018 | 0.4568M |
| June 30, 2018 | 0.7129M |
| March 31, 2018 | 0.4934M |
| December 31, 2017 | 0.2366M |
| September 30, 2017 | 0.1516M |
| June 30, 2017 | 0.2846M |
| March 31, 2017 | 0.2473M |
| December 31, 2016 | 0.1604M |
| September 30, 2016 | 0.3156M |
| June 30, 2016 | 0.4544M |
| March 31, 2016 | 0.6513M |
| December 31, 2015 | 0.3783M |
| September 30, 2015 | 0.1944M |
| June 30, 2015 | 0.0622M |
| March 31, 2015 | 0.3191M |
| December 31, 2014 | 0.4487M |
| September 30, 2014 | 0.2406M |
| June 30, 2014 | 0.0702M |
| March 31, 2014 | 0.1849M |
| December 31, 2013 | 0.0933M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
| Clearmind Medicine, Inc. | 3.033M |
| Lexaria Bioscience Corp. | 0.4371M |
| Target Group, Inc. (Canada) | 14.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.134M |
| Shareholders Equity (Quarterly) | 6.892M |
| Debt to Equity Ratio | 0.061 |
| Current Ratio | 3.115 |
| Net Debt Paydown Yield | 4.95% |